Abstract:BACKGROUND: Inflammatory responses in injured nerves have been recognized as important factors for initially sensitizing nociceptive neurons. Cyclooxygenase (COX) is the rate-limiting enzyme in prostaglandin synthesis, and COX-2 inhibitor is involved in mechanisms of analgesia and anti-inflammation.OBJECTIVE: To investigate the effects of COX-2 inhibitor on thermal and mechanical hyperalgesia, as well as expression of growth associated protein 43 (GAP-43) and nerve growth factor (NGF) in dorsal root ganglion, in a rat model of neuropathic pain due to chronic constriction injury.DESIGN, TIME AND SETTING: A randomized, controlled, comparison study that was performed at the Surgical Department and Pathological Laboratory, Second Affiliated Hospital of Shantou University Medical College from September 2006 to September 2007.MATERIALS: COX-2 inhibitor, lornoxicam, was purchased from Nycomed Pharmaceutical (Austria); rabbit anti-GAP-43, and rabbit anti-NGF polyclonal antibodies were purchased from Boster, Wuhan, China.METHODS: A total of 50 adult, Wistar rats were randomly assigned to four groups: normal control (n = 5), model (n = 15), normal saline control (n = 15), and lornoxicam treatment (n = 15). With exception of the control group, the sciatic nerve of all rats was loosely ligated to establish a model of chronic constriction injury. The model rats were divided into three subgroups according to varying post-operative survival periods: 3, 7 and 14 days (n = 5), respectively. Rats in the lornoxicam treatment group were intraperitoneally injected with 1.3 mg/kg lornoxicam every 12 hours throughout the entire experimental procedure. Rats in the normal saline control group were intraperitoneally injected with 1.3 mL/kg saline.MAIN OUTCOME MEASURES: Immunohistochemistry revealed expression of GAP-43 and NGF in the L5 dorsal root ganglions. Mechanical withdrawal threshold and thermal withdrawal latency were used to observe neurological behavioral changes in rats.RESULTS: The relative gray values of GAP-43- and NGF-positive neurons in the model group were remarkably increased compared with the normal control rats (P < 0.01), while the relative gray values in the lomoxicam treatment group were significantly less than the model and normal saline control groups (P < 0.01). Mechanical withdrawal threshold and thermal withdrawal latency gradually decreased with increasing injury time in the model, normal saline control, and lornoxicam treatment groups, and were significantly less than the normal control group (P < 0.05). In addition, mechanical withdrawal threshold and thermal Withdrawal latency were significantly greater in the lornoxicam treatment group compared with the model and normal saline control groups (P < 0.05).CONCLUSION: Intraperitoneal injection of the COX-2 inhibitor lornoxicam attenuated mechanical and thermal hyperalgesia induced by sciatic nerve chronic constriction injury and inhibited the increased expression of GAP-43 and NGF.

Pathophysiological effects of nerve growth factor on osteoarthritic cartilage

Mechanism and Therapeutic Effectiveness of Nerve Growth Factor in Osteoarthritis Pain

Mechanism and therapeutic effectiveness of nerve growth factor in osteoarthritis pain.

Progress in Study of Nerve Growth Factor and Its Receptors on Mechanism of Endometriosis Pain

Nerve Growth Factor Receptor Limits Inflammation to Promote Remodeling and Repair of Osteoarthritic Joints

Cartilage stem/progenitor cells are activated in osteoarthritis via interleukin-1β/nerve growth factor signaling.

The Efficacy of Nerve Growth Factor Antibody for the Treatment of Osteoarthritis Pain and Chronic Low-Back Pain: A Meta-Analysis

Targeting nerve growth factor for pain relief: pros and cons

Decreased GDNF Mrna Expression in Dorsal Spinal Cord of Unilateral Arthritic Rat.

The pro-inflammatory effect of NR4A3 in osteoarthritis

Nesfatin-1 suppresses interleukin-1 beta-induced inflammation, apoptosis, and cartilage matrix destruction in chondrocytes and ameliorates osteoarthritis in rats

Impacts of anti-nerve growth factor antibody on pain-related behaviors and expressions of opioid receptor in spinal dorsal horn and dorsal root ganglia of rats with cancer-induced bone pain

EFFECTS OF GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR ON THE PRODUCT OF NO AND THE ACTIVITY OF NOS IN SPINAL CORD IN RATS MODEL OF NEUROPATHIC PAIN

Effect of Extracellular Ribonucleic Acids on Neurovascularization in Osteoarthritis

Effect of Mouse Nerve Growth Factor on Osteoporosis after Peripheral Nerve Injury

The Effect Of Experimental Occlusal Interferences On Nerve Growth Factor Levels In Periodontal Tissues

Estrogen Regulation of the Expression of Pain Factor NGF in Rat Chondrocytes.

Mechanisms of nerve growth factor signaling in bone nociceptors and in an animal model of inflammatory bone pain

Effects of Cyclooxygenase 2 Inhibitor on Growth-Associated Protein 43 and Nerve Growth Factor Expression in Dorsal Root Ganglion During Neuropathic Pain Development

Nerve Growth Factor and Peripheral Neuropathy

Role of NGF-TrkA signaling in calcification of articular chondrocytes